SECURITIES AND EXCHANGE COMMISSION
     Washington, D.C.

     Litigation Release No. 15572 / November 25, 1997

     Accounting and Auditing Enforcement 
     Release No. 990 / November 25, 1997

     Securities and Exchange Commission v. HealthTech International, Inc. Civil
     Action No.  97 CV 8766 (JSR)

     The Securities and Exchange Commission announced that it filed a Complaint
     in federal district court in Manhattan today charging HealthTech
     International, Inc. ("HealthTech") with fraudulently overstating its assets
     in its periodic reports filed with the Commission and disseminated to the
     public, including a 55% overstatement in its most recently filed financial
     statements.  Without admitting or denying the allegations in the
     Commission's Complaint, HealthTech, which operates health clubs in Texas,
     Oregon and Arizona, consented to the entry of a Final Judgment permanently
     enjoining HealthTech from violating the antifraud, corporate reporting, and
     corporate recordkeeping provisions of the federal securities laws. 
     HealthTech also has agreed to be ordered to:  (1) correct any misstatements
     contained in its last five periodic reports (covering its 1995 and 1996
     fiscal years and the first three quarters of its current fiscal year) and
     in its press releases issued since September 30, 1995; and (2) restate its
     financial statements for the fiscal years ended September 30, 1995 and
     September 30, 1996, and for each of fiscal quarters ended December 31,
     1996, March 31, 1997, and June 30, 1997.

     The Complaint alleges that HealthTech has been overstating its assets by at
     least $10 million by: (1) reporting a sports club owned by the company on
     its books and in its financial statements at a purported cost of $5,875,000
     when it should have reported the property at $725,000; (2) improperly
     inflating by at least
     $5 million the value of advertising credits acquired by the company; and
     (3) overstating the value of assets acquired by the company with those
     advertising credits.

     Previously, on November 17, 1997, the Commission issued an order pursuant
     to Section 12(k) of the Securities Exchange Act of 1934 suspending the
     over-the-counter trading of the securities of HealthTech for a ten-day
     period because of questions that had been raised about the adequacy and
     accuracy of publicly disseminated information about HealthTech concerning,
     among other things, its financial condition and acquisitions made by the
     company.

     The Commission thanks the NASDAQ, Listing Investigations for its assistance
     in this matter.





                              ======END OF PAGE 1======